BACKGROUND:Patients with diabetes mellitus (DM) have a higher risk of sudden cardiac death. Factors associated with the risk profiles of coronary artery disease (CAD) patients with DM are not well established. Heart rate turbulence (HRT) and T-wave alternans (TWA) are often used to predict arrhythmia events. METHODS AND RESULTS:HRT and TWA were measured in two independent groups: the ARTEMIS cohort study and the REFINE-ICD randomized trial. ARTEMIS assesses risk 3-12 months after coronary angiography in patients with CAD. The initial 1001 patients in ARTEMIS, 526 with and 475 without DM, are included in this analysis. REFINE-ICD compares usual care versus usual care plus ICD therapy in patients with left ventricular (LV) ejection fraction (EF) values of 36-50% assessed 2-15 months after myocardial infarction. The initial 275 patients screened in REFINE ICD are included in this analysis. Abnormal HRT plus TWA was more common in patients with versus without DM in ARTEMIS (125/526, 24% vs 63/475, 13%; P < 0.001) and REFINE-ICD (43/55, 78% vs 55/220, 25%; P < 0.001), respectively. Abnormal HRT plus TWA was also more common in patients with LVEF values < 50% (28%) vs ≥ 50% (18%; P < 0.001) in ARTEMIS and LVEF values below the population median of 42% (60/138, 43%) versus above the median (38/137, 28%; P < 0.01) in REFINE-ICD. CONCLUSIONS:Abnormal HRT plus TWA is more common in CAD patients with DM compared with the patients without DM and is related to the severity of LV dysfunction. CLINICAL TRIAL REGISTRATION INFORMATION: http://www.clinicaltrials.gov, NCT01426685; http://www.clinicaltrials.gov, NCT00673842.
RCT Entities:
BACKGROUND:Patients with diabetes mellitus (DM) have a higher risk of sudden cardiac death. Factors associated with the risk profiles of coronary artery disease (CAD) patients with DM are not well established. Heart rate turbulence (HRT) and T-wave alternans (TWA) are often used to predict arrhythmia events. METHODS AND RESULTS: HRT and TWA were measured in two independent groups: the ARTEMIS cohort study and the REFINE-ICD randomized trial. ARTEMIS assesses risk 3-12 months after coronary angiography in patients with CAD. The initial 1001 patients in ARTEMIS, 526 with and 475 without DM, are included in this analysis. REFINE-ICD compares usual care versus usual care plus ICD therapy in patients with left ventricular (LV) ejection fraction (EF) values of 36-50% assessed 2-15 months after myocardial infarction. The initial 275 patients screened in REFINE ICD are included in this analysis. Abnormal HRT plus TWA was more common in patients with versus without DM in ARTEMIS (125/526, 24% vs 63/475, 13%; P < 0.001) and REFINE-ICD (43/55, 78% vs 55/220, 25%; P < 0.001), respectively. Abnormal HRT plus TWA was also more common in patients with LVEF values < 50% (28%) vs ≥ 50% (18%; P < 0.001) in ARTEMIS and LVEF values below the population median of 42% (60/138, 43%) versus above the median (38/137, 28%; P < 0.01) in REFINE-ICD. CONCLUSIONS:Abnormal HRT plus TWA is more common in CAD patients with DM compared with the patients without DM and is related to the severity of LV dysfunction. CLINICAL TRIAL REGISTRATION INFORMATION: http://www.clinicaltrials.gov, NCT01426685; http://www.clinicaltrials.gov, NCT00673842.
Authors: Axel Bauer; Marek Malik; Georg Schmidt; Petra Barthel; Hendrik Bonnemeier; Iwona Cygankiewicz; Przemyslaw Guzik; Federico Lombardi; Alexander Müller; Ali Oto; Raphael Schneider; Mari Watanabe; Dan Wichterle; Wojciech Zareba Journal: J Am Coll Cardiol Date: 2008-10-21 Impact factor: 24.094
Authors: Derek V Exner; Katherine M Kavanagh; Michael P Slawnych; L Brent Mitchell; Darlene Ramadan; Sandeep G Aggarwal; Catherine Noullett; Allie Van Schaik; Ryan T Mitchell; Mariko A Shibata; Sajad Gulamhussein; James McMeekin; Wayne Tymchak; Gregory Schnell; Anne M Gillis; Robert S Sheldon; Gordon H Fick; Henry J Duff Journal: J Am Coll Cardiol Date: 2007-11-26 Impact factor: 24.094
Authors: Michael P Slawnych; Tuomo Nieminen; Mika Kähönen; Katherine M Kavanagh; Terho Lehtimäki; Darlene Ramadan; Jari Viik; Sandeep G Aggarwal; Rami Lehtinen; Linda Ellis; Kjell Nikus; Derek V Exner Journal: J Am Coll Cardiol Date: 2009-03-31 Impact factor: 24.094
Authors: Tuomo Nieminen; Terho Lehtimäki; Jari Viik; Rami Lehtinen; Kjell Nikus; Tiit Kööbi; Kari Niemelä; Väinö Turjanmaa; Willi Kaiser; Heini Huhtala; Richard L Verrier; Heikki Huikuri; Mika Kähönen Journal: Eur Heart J Date: 2007-07-25 Impact factor: 29.983
Authors: Heikki V Huikuri; M J Pekka Raatikainen; Rikke Moerch-Joergensen; Juha Hartikainen; Vesa Virtanen; Jean Boland; Olli Anttonen; Nis Hoest; Lucas V A Boersma; Eivind S Platou; Marc D Messier; Poul-Erik Bloch-Thomsen Journal: Eur Heart J Date: 2009-01-20 Impact factor: 29.983
Authors: Neal A Chatterjee; Jani T Tikkanen; Gopi K Panicker; Dhiraj Narula; Daniel C Lee; Tuomas Kentta; Juhani M Junttila; Nancy R Cook; Alan Kadish; Jeffrey J Goldberger; Heikki V Huikuri; Christine M Albert Journal: Eur Heart J Date: 2020-06-01 Impact factor: 29.983
Authors: Selcuk Adabag; Kristen K Patton; Alfred E Buxton; Thomas S Rector; Kristine E Ensrud; Kairav Vakil; Wayne C Levy; Jeanne E Poole Journal: JAMA Cardiol Date: 2017-07-01 Impact factor: 14.676
Authors: Alexander Steger; Alexander Müller; Petra Barthel; Michael Dommasch; Katharina Maria Huster; Katerina Hnatkova; Daniel Sinnecker; Alexander Hapfelmeier; Marek Malik; Georg Schmidt Journal: Front Physiol Date: 2019-02-04 Impact factor: 4.566